Document Detail

Outcome of infants born to women with chronic kidney disease.
MedLine Citation:
PMID:  17395122     Owner:  NLM     Status:  MEDLINE    
Pregnancy in women with chronic kidney disease is not uncommon and is not without risk to the mother and child. This article reviews the literature on the outcome of infants from pregnancies in women with chronic kidney disease (CKD), including those receiving dialysis and those living with a functional kidney transplant. Pregnancy in women with CKD and end-stage renal disease (ESRD) is associated with a higher rate of premature birth and small-for-gestational-age (SGA) infants, with resultant increase in neonatal mortality. Although congenital anomalies or long-term developmental issues do not appear to be a significant risk, these areas deserve further study, especially as newer immunosuppressive medications are employed in kidney transplant recipients.
Douglas L Blowey; Bradley A Warady
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Advances in chronic kidney disease     Volume:  14     ISSN:  1548-5595     ISO Abbreviation:  -     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-03-30     Completed Date:  2007-06-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101209214     Medline TA:  Adv Chronic Kidney Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  199-205     Citation Subset:  IM    
Department of Pediatrics, Children's Mercy Hospitals & Clinics, University of Missouri at Kansas City, Kansas City, MO, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin II Type 1 Receptor Blockers / administration & dosage,  adverse effects
Angiotensin-Converting Enzyme Inhibitors / administration & dosage,  adverse effects
Child Development
Chronic Disease
Congenital Abnormalities / epidemiology
Infant Mortality
Infant, Newborn
Kidney Diseases / complications*,  therapy
Kidney Transplantation
Pregnancy Outcome*
Renal Dialysis
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Medications during pregnancy: antihypertensives and immunosuppressives.
Next Document:  Ethical considerations regarding pregnancy in chronic kidney disease.